Bristol Plavix Launch Sales Are $19 Mil.; PCS Grows 53% With Mail Order
Executive Summary
Bristol-Myers Squibb's first month co-marketing the platelet aggregation inhibitor Plavix contributed $19 mil. in revenue to the company, Bristol reported.
You may also be interested in...
Sanofi-Aventis’ CEO Pipeline: R&D Chief Le Fur Tapped To Succeed Dehecq
Incoming Sanofi-Aventis CEO Gerard Le Fur will bring considerable research and development experience to the helm of the French drug maker
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011